20 Einträge gefunden

1. Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany

   1. Zander, N
   2. Naatz, M
   3. Augustin, M
   4. Langenbruch, A
   5. Topp, J
   6. Mrowietz, U
   7. von Kiedrowski, R

   2021 - Forschungsinformationssystem des UKE
2. Validación de la versión española del Cuestionario Wound-QoL:Validation of the Spanish Wound-QoL Questionnaire

   1. Conde Montero, E
   2. Sommer, R
   3. Augustin, M
   4. Blome, C
   5. Cabeza Martínez, R
   6. Horcajada Reales, C
   7. Alsina Gibert, M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study

   1. Augustin, M
   2. Kleyn, C E
   3. Conrad, C
   4. Sator, P G
   5. Ståhle, M
   6. Eyerich, K
   7. Radtke, M A

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa, Epidemiologie, Patientenlebensqualität und Behandlungskosten der Hidradenitis suppurativa/Acne inversa

   1. Kirsten, N
   2. Frings, V
   3. Nikolakis, G D
   4. Presser, D
   5. Goebeler, M
   6. Zouboulis, C C
   7. Augustin, M

   2021 - Forschungsinformationssystem des UKE
5. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review

   1. von Stülpnagel, C C
   2. Augustin, M
   3. Düpmann, L
   4. da Silva, N
   5. Sommer, R

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Statutory skin cancer screening in Germany:Motivation and motives for participation versus nonparticipation, Gesetzliches Hautkrebsscreening in Deutschland.:Motivation und Motive zur Teilnahme versus Nichtteilnahme

   1. Girbig, G
   2. Augustin, M
   3. Krensel, M
   4. Andrees, V

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Stigma in visible skin diseases - A literature review and development of a conceptual model

   1. Germain, N
   2. Augustin, M
   3. François, C
   4. Legau, K
   5. Bogoeva, N
   6. Desroches, M
   7. Toumi, M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: A comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort

   1. Zeidler, C
   2. Pereira, M P
   3. Dugas, M
   4. Augustin, M
   5. Storck, M
   6. Weyer-Elberich, V
   7. Schneider, G

   2021 - Forschungsinformationssystem des UKE
9. Network meta-analyses in psoriasis: overview and critical discussion

   1. Augustin, M
   2. Valencia López, Maria José
   3. Reich, K

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

    1. Pinter, A
    2. Hoffmann, M
    3. Reich, K
    4. Augustin, M
    5. Kaplan, K
    6. Gudjónsdóttir, S D
    7. Delvin, T

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
11. The value of subcutaneous vs. oral methotrexate: real-world data from the German psoriasis registry PsoBest

    1. Reich, K
    2. Sorbe, C
    3. Griese, L
    4. Reich, J L K
    5. Augustin, M

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
12. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

    1. Leutz, A
    2. Pinter, A
    3. Thaçi, D
    4. Augustin, M
    5. Schuster, C
    6. Fotiou, K
    7. Hundemer, H P

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
13. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

    1. Augustin, M
    2. Dauden, E
    3. Mrowietz, U
    4. Konstantinou, M P
    5. Gerdes, S
    6. Kingo, K
    7. Szepietowski, J C

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
14. Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study

    1. Reich, K
    2. Sullivan, J
    3. Arenberger, P
    4. Jazayeri, S
    5. Mrowietz, U
    6. Augustin, M
    7. Elewski, B

    2021 - Forschungsinformationssystem des UKE
15. Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasis

    1. Sommer, R
    2. Augustin, M
    3. Hilbring, C
    4. Ständer, Sonja
    5. Hubo, M
    6. Hutt, H J
    7. von Stülpnagel, C C

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
16. Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care

    1. Mohr, N
    2. Naatz, M
    3. Zeervi, L
    4. Langenbruch, A
    5. Bieber, T
    6. Werfel, T
    7. Wollenberg, A

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
17. Pruritus Intensity Scales across Europe: A Prospective Validation Study

    1. Storck, M
    2. Sandmann, S
    3. Bruland, P
    4. Pereira, M P
    5. Steinke, S
    6. Riepe, C
    7. Soto-Rey, I

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
18. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

    1. Wollenberg, A
    2. Nakahara, T
    3. Maari, C
    4. Peris, K
    5. Lio, P
    6. Augustin, M
    7. Silverberg, J I

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
19. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study

    1. Maul, J-T
    2. Augustin, M
    3. Sorbe, C
    4. Conrad, C
    5. Anzengruber, F
    6. Mrowietz, U
    7. Reich, K

    2021 - Forschungsinformationssystem des UKE
20. Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial

    1. Warren, R B
    2. Lebwohl, M
    3. Sofen, H
    4. Piguet, V
    5. Augustin, M
    6. Brock, F
    7. C Arendt,

    2021 - Forschungsinformationssystem des UKE - frei zugänglich